<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.coughjournal.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Cough - Latest Articles</title>
        <link>http://www.coughjournal.com</link>
        <description>The latest research articles published by Cough</description>
        <dc:date>2009-06-25T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/5/1/6" />
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/5/1/5" />
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/5/1/4" />
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/5/1/3" />
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/5/1/2" />
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/5/1/1" />
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/4/1/11" />
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/4/1/10" />
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/4/1/9" />
                                <rdf:li rdf:resource="http://www.coughjournal.com/content/4/1/8" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.coughjournal.com/content/5/1/6">
        <title>Cough and dyspnea during bronchoconstriction: comparison of different stimuli</title>
        <description>Background:
Bronchial challenge tests are used to evaluate bronchial responsiveness in diagnosis and follow-up of asthmatic patients. Challenge induced cough has increasingly been recognized as a valuable diagnostic tool. Various stimuli and protocols have been employed. The aim of this study was to compare cough and dyspnea intensity induced by different stimuli.
Methods:
Twenty asthmatic patients underwent challenge tests with methacholine, bradykinin and exercise. Cough was counted during challenge tests. Dyspnea was assessed by modified Borg scale and visual analogue scale. Statistical comparisons were performed by linear mixed-effects model.
Results:
For cough evaluation, bradykinin was the most potent trigger (p[less than]0.01). In terms of dyspnea measured by Borg scale, there were no differences among stimuli (p[more than]0.05). By visual analogue scale, bradykinin induced more dyspnea than other stimuli (p[less than or equal to]0.04).
Conclusions:
Bradykinin seems to be the most suitable stimulus for bronchial challenge tests intended for measuring cough in association with bronchoconstriction.</description>
        <link>http://www.coughjournal.com/content/5/1/6</link>
                <dc:creator>Thais Suguikawa</dc:creator>
                <dc:creator>Clecia Garcia</dc:creator>
                <dc:creator>Edson Martinez</dc:creator>
                <dc:creator>Elcio Vianna</dc:creator>
                <dc:source>Cough 2009, 5:6</dc:source>
        <dc:date>2009-06-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-5-6</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2009-06-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.coughjournal.com/content/5/1/5">
        <title>Measuring cough severity: perspectives from the literature and from patients with chronic cough</title>
        <description>Background:
In order to assess severity of cough from patients&apos; perspectives and capture the effects of treatment in clinical trials, a measurement tool must show evidence of validity and reliability. The purpose of this study was to characterize cough severity from patients&apos; perspectives as the initial step in the development of a new patient-reported outcome (PRO) measure for use in clinical trials.
Methods:
This focus groups study included patients with clinician confirmed chronic cough recruited from a large internal medicine clinic in the US. A semi-structured focus group guide was designed to elicit information about patients&apos; experiences with cough severity and their characterization of symptoms. The focus group data were coded to identify concepts and terminology of cough severity.
Results:
Three focus groups were conducted [n = 22; 6 male; mean age 66.1 (&#177; 12.9)]. Etiology included GERD, asthma, bronchitis, post-nasal drip, and other. Three domains of cough severity were identified: frequency, intensity, and disruption. In addition to a single cough, participants in all focus groups described coughing in uncontrollable paroxysms they called &quot;fits,&quot; &quot;bouts,&quot; &quot;spells,&quot; or &quot;episodes.&quot; The urge to cough, described as an important sign of impending cough, was considered a component of cough frequency. Participants also described daytime activity and nighttime sleep disruption as an indication of cough severity. Finally, participants described variability in cough severity.
Conclusion:
Results suggest that patients describe cough severity in terms of frequency, intensity, and disruptiveness, indicating these 3 domains should be addressed when evaluating cough severity and outcomes of treatment.</description>
        <link>http://www.coughjournal.com/content/5/1/5</link>
                <dc:creator>Margaret Vernon</dc:creator>
                <dc:creator>Nancy Kline Leidy</dc:creator>
                <dc:creator>Alise Nacson</dc:creator>
                <dc:creator>Linda Nelsen</dc:creator>
                <dc:source>Cough 2009, 5:5</dc:source>
        <dc:date>2009-03-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-5-5</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2009-03-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.coughjournal.com/content/5/1/4">
        <title>Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement</title>
        <description>RationaleChronic persistent cough can be associated with laryngeal dysfunction that leads to symptoms such as dysphonia, sensory hyperresponsiveness to capsaicin, and motor dysfunction with paradoxical vocal fold movement and variable extrathoracic airflow obstruction (reduced inspiratory airflow). Successful therapy of chronic persistent cough improves symptoms and sensory hyperresponsiveness. The effects of treatment for chronic cough on laryngeal dysfunction are not known.ObjectiveThe aim of this study was to investigate effects of therapy for chronic cough and paradoxical vocal fold movement.
Methods:
Adults with chronic cough (n = 24) were assessed before and after treatment for chronic persistent cough by measuring quality of life, extrathoracic airway hyperresponsiveness to hypertonic saline provocation, capsaicin cough reflex hypersensitivity and fibreoptic laryngoscopy to observe paradoxical vocal fold movement. Subjects with chronic cough were classified into those with (n = 14) or without (n = 10) paradoxical vocal fold movement based on direct observation at laryngoscopy.
Results:
Following treatment there was a significant improvement in cough related quality of life and cough reflex sensitivity in both groups. Subjects with chronic cough and paradoxical vocal fold movement also had additional improvements in extrathoracic airway hyperresponsiveness and paradoxical vocal fold movement. The degree of improvement in cough reflex sensitivity correlated with the improvement in extrathoracic airway hyperresponsiveness.
Conclusion:
Laryngeal dysfunction is common in chronic persistent cough, where it is manifest as paradoxical vocal fold movement and extrathoracic airway hyperresponsiveness. Successful treatment for chronic persistent cough leads to improvements in these features of laryngeal dysfunction.</description>
        <link>http://www.coughjournal.com/content/5/1/4</link>
                <dc:creator>Nicole Ryan</dc:creator>
                <dc:creator>Anne Vertigan</dc:creator>
                <dc:creator>Peter Gibson</dc:creator>
                <dc:source>Cough 2009, 5:4</dc:source>
        <dc:date>2009-03-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-5-4</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2009-03-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.coughjournal.com/content/5/1/3">
        <title>Features of cough variant asthma and classic asthma during methacholine-induced brochoconstriction: a cross-sectional study</title>
        <description>Background:
Little is known regarding mechanistic and phenotypic differences between cough variant asthma (CVA), presenting with a chronic cough as the sole symptom that responds to bronchodilators, and classic asthma with wheezing during methacholine inhalation. Here we reported airway sensitivity, airway reactivity, and as the main concern, the appearance of cough and wheezes during methacholine inhalation in patients with CVA or classic asthma.
Methods:
We cross-sectionally examined the degrees of airway sensitivity, the point where resistance started to increase, and reactivity, the slope of the methacholine-resistance curve, and the appearance of cough and wheezes in steroid-na&#239;ve adult patients with classic asthma (n = 58) or CVA (n = 55) while they were continuously inhaling methacholine during simultaneous measurement of respiratory resistance.
Results:
Patients with CVA were less sensitive and less reactive to inhaled methacholine and wheezed less frequently but coughed more frequently during methacholine-induced bronchoconstriction than did patients with classic asthma. Multivariate analysis revealed that airway hypersensitivity and lower baseline FEV1/FVC were associated with the appearance of wheezes, whereas a diagnosis of CVA was associated with coughing.
Conclusion:
There are mechanistic and phenotypic differences between CVA and classic asthma during methacholine inhalation. Frequent coughing during bronchoconstriction may be a distinctive feature of CVA.</description>
        <link>http://www.coughjournal.com/content/5/1/3</link>
                <dc:creator>Hisako Matsumoto</dc:creator>
                <dc:creator>Akio Niimi</dc:creator>
                <dc:creator>Masaya Takemura</dc:creator>
                <dc:creator>Tetsuya Ueda</dc:creator>
                <dc:creator>Masafumi Yamaguchi</dc:creator>
                <dc:creator>Hirofumi Matsuoka</dc:creator>
                <dc:creator>Makiko Jinnai</dc:creator>
                <dc:creator>Kazuo Chin</dc:creator>
                <dc:creator>Michiaki Mishima</dc:creator>
                <dc:source>Cough 2009, 5:3</dc:source>
        <dc:date>2009-03-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-5-3</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2009-03-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.coughjournal.com/content/5/1/2">
        <title>Childhood habit cough treated with consultation by telephone:  a case report</title>
        <description>Background:
Childhood habit cough has been treated successfully by making suggestions that it can be stopped, desensitization techniques, use of distractors, provision of rewards, and self-hypnosis. All of these techniques have involved personal contact between a health care provider and a patient.Case presentationA 5-year-old with cystic fibrosis was diagnosed with habit cough following evaluation by a pediatric pulmonologist and otolaryngologist. An expert in the treatment of habit cough provided instruction by telephone to the patient&apos;s mother regarding use of hypnotic techniques in this setting, which was associated with resolution of the cough within a week.
Conclusion:
As this report describes a single patient, it is possible that his improvement was unrelated to the given advice. Therefore, it remains to be seen whether therapy by telephone for habit cough is applicable widely.</description>
        <link>http://www.coughjournal.com/content/5/1/2</link>
                <dc:creator>Ran Anbar</dc:creator>
                <dc:source>Cough 2009, 5:2</dc:source>
        <dc:date>2009-01-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-5-2</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2009-01-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.coughjournal.com/content/5/1/1">
        <title>Cough in adult cystic fibrosis: diagnosis and response to fundoplication</title>
        <description>Background:
Gastroesophageal reflux is one of the most common causes of chronic cough in the general population. Reflux occurs frequently in patients with cystic fibrosis (CF). We undertook laparoscopic Nissen fundoplication in adult CF patients with a clinical diagnosis of reflux cough who had failed conventional medical therapies.ObjectiveWe determined the response to the surgical route in the treatment of intractable reflux cough in CF.MethodPatients with refractory cough were assessed by 24 h pH monitoring and oesophageal manometry. Pre-and post-operation cough, lung function and exacerbation frequency were compared. Cough was assessed by the Leicester Cough Questionnaire (LCQ), lung function by spirometry and exacerbation frequency was defined by comparing the postoperative epoch with a similar preoperatively.
Results:
Significant abnormalities of oesophageal function were seen in all patients studied. 6 patients (2 females), with the mean age of 34.5 years consented to surgery. Their mean number of reflux episodes was 144.4, mean DeMeester score was 39.2, and mean lower oesophageal sphincter pressure 12.4 mmHg. There was a small change in the FEV1 from 1.03 L to 1.17 (P = 0.04), and FVC improved from 2.62 to 2.87 (P = 0.05). Fundoplication lead to a marked fall in cough with the total LCQ score increasing from 11.9 to 18.3 (P = 0.01). Exacerbation events were reduced by 50% post operatively.
Conclusion:
Whilst there is an obvious attention to respiratory causes of cough in CF, reflux is also a common cause. Fundoplication is highly effective in the control of reflux cough in CF. Significant reduction in exacerbation frequency may indicate that reflux with possible aspiration is a major unrecognised contributor to airway disease.</description>
        <link>http://www.coughjournal.com/content/5/1/1</link>
                <dc:creator>Hosnieh Fathi</dc:creator>
                <dc:creator>Tanya Moon</dc:creator>
                <dc:creator>Jo Donaldson</dc:creator>
                <dc:creator>Warren Jackson</dc:creator>
                <dc:creator>Peter Sedman</dc:creator>
                <dc:creator>Alyn Morice</dc:creator>
                <dc:source>Cough 2009, 5:1</dc:source>
        <dc:date>2009-01-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-5-1</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2009-01-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.coughjournal.com/content/4/1/11">
        <title>Impaired urge-to-cough in elderly patients with aspiration pneumonia</title>
        <description>Background:
The down-regulation of the cough reflex in patients with aspiration pneumonia can involve both cortical facilitatory pathways for cough and medullary reflex pathways. In order to study the possible involvement of the supramedullary system in the down-regulation of cough reflex, we evaluated the urge-to-cough in patients with aspiration pneumonia.
Methods:
Cough reflex sensitivity and the urge-to-cough to inhaled citric acid were evaluated in patients with at least a history of aspiration pneumonia and age-matched healthy elderly people. The cough reflex sensitivities were defined as the lowest concentration of citric acid that elicited two or more coughs (C2) and five or more coughs (C5). The urge-to-cough scores at the concentration of C2 and C5, and at the concentration of two times dilution of C2 (C2/2) and C5 (C5/2) were estimated for each subject.
Results:
Both C2 and C5 in the control subjects were significantly greater than those for patients with aspiration pneumonia. There were no significant differences in the urge-to-cough at C2 and C5 between control subjects and patients with aspiration pneumonia. However, the urge-to-cough scores at both C2/2 and C5/2 in patients with aspiration pneumonia were significantly lower than those in control subjects. The number of coughs at C5/2 was significantly greater in the control subjects than those in the patients with aspiration pneumonia whereas the number of coughs at C2/2 did not show a significant difference between the control subjects and the patients with aspiration pneumonia.
Conclusion:
The study suggests the involvement of supramedullary dysfunction in the etiology of aspiration pneumonia in the elderly. Therefore, restoration of the cough motivation system could be a new strategy to prevent aspiration pneumonia in the elderly.</description>
        <link>http://www.coughjournal.com/content/4/1/11</link>
                <dc:creator>Shinsuke Yamanda</dc:creator>
                <dc:creator>Satoru Ebihara</dc:creator>
                <dc:creator>Takae Ebihara</dc:creator>
                <dc:creator>Miyako Yamasaki</dc:creator>
                <dc:creator>Takaaki Asamura</dc:creator>
                <dc:creator>Masanori Asada</dc:creator>
                <dc:creator>Kaori Une</dc:creator>
                <dc:creator>Hiroyuki Arai</dc:creator>
                <dc:source>Cough 2008, 4:11</dc:source>
        <dc:date>2008-11-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-4-11</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2008-11-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.coughjournal.com/content/4/1/10">
        <title>The utility of the mannitol challenge in the assessment of chronic cough: a pilot study </title>
        <description>There is a need for more objective outcome measures for chronic cough. In this pilot study we sought to investigate the utility of the mannitol challenge as a cough-provocation test in non-asthmatic chronic cough. We studied 16 healthy controls and 13 subjects with chronic cough. We assessed cough severity using a visual analogue score, capsaicin cough sensitivity, health status using the Leicester Cough Questionnaire and the dose of mannitol to cause 2 (C2) or 5 (C5) coughs. In all of the subjects with chronic cough and 6 of the controls we assessed the 1-week repeatability of the mannitol challenge. We found that in those subjects with chronic cough the geometric mean (logSEM) mannitol C2 and C5 was heightened compared to controls (C2: 4 (0.2) versus 16 (0.1); p = 0.04 and C5: 63 (0.1) versus 251 (0.1); p = 0.04). Cough visual analogue score, capsacin-induced cough sensitivity and health status were also altered in chronic cough compared to healthy controls, but in those subjects with chronic cough none of these outcomes was correlated with the mannitol C2 or C5. The repeatability of the mannitol challenge assessed by intraclass correlation was C2 = 0.53 and C5 = 0.59. A cut-off in the dose of mannitol of 62 mg/ml for C2 and 550 mg/ml for C5 had a sensitivity of 69 and 62% and specificity of 69 and 81% respectively to distinguish chronic coughers from healthy controls. In conclusion, the mannitol challenge my have potential as a novel cough challenge test and further work is required to extend our findings and to assess whether it has utility in different causes of chronic cough.</description>
        <link>http://www.coughjournal.com/content/4/1/10</link>
                <dc:creator>Amisha Singapuri</dc:creator>
                <dc:creator>Susan McKenna</dc:creator>
                <dc:creator>Christopher Brightling</dc:creator>
                <dc:source>Cough 2008, 4:10</dc:source>
        <dc:date>2008-11-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-4-10</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2008-11-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.coughjournal.com/content/4/1/9">
        <title>Immunohistochemical characterization of nodose cough receptor neurons projecting to the trachea of guinea pigs</title>
        <description>Background:
Cough in guinea pigs is mediated in part by capsaicin-insensitive low threshold mechanoreceptors (cough receptors). Functional studies suggest that cough receptors represent a homogeneous population of nodose ganglia-derived sensory neurons. In the present study we set out to characterize the neurochemical profile of cough receptor neurons in the nodose ganglia.
Methods:
Nodose neurons projecting to the guinea pig trachea were retrogradely labeled with fluorogold and processed immunohistochemically for the expression of a variety of transporters (Na+/K+/2C1- co-transporter (NKCC1), &#945;1 and &#945;3 Na+/K+ ATPase, vesicular glutamate transporters (vGlut)1 and vGlut2), neurotransmitters (substance P, calcitonin gene-related peptide (CGRP), somatostatin, neuronal nitric oxide synthase (nNOS)) and cytosolic proteins (neurofilament, calretinin, calbindin, parvalbumin).
Results:
Fluorogold labeled ~3 per cent of neurons in the nodose ganglia with an average somal perimeter of 137 &#177; 6.2 &#956;m (range 90&#8211;200 &#956;m). All traced neurons (and seemingly all nodose neurons) were immunoreactive for NKCC1. Many (&gt; 90 per cent) were also immunoreactive for vGlut2 and neurofilament and between 50 and 85 per cent expressed &#945;1 ATPase, &#945;3 ATPase or vGlut1. Cough receptor neurons that did not express the above markers could not be differentiated based on somal size, with the exception of neurofilament negative neurons which were significantly smaller (P &lt; 0.05). Less than 10 per cent of fluorogold labeled neurons expressed substance P or CGRP (and these had somal perimeters less than 110 &#956;m) and none expressed somatostatin, calretinin, calbindin or parvalbumin. Two distinct patterns of nNOS labeling was observed in the general population of nodose neurons: most neurons contained cytosolic clusters of moderately intense immunoreactivity whereas less than 10 per cent of neurons displayed uniform intensely fluorescent somal labeling. Less than 3 per cent of the retrogradely traced neurons were intensely fluorescent for nNOS (most showed clusters of nNOS immunoreactivity) and nNOS immunoreactivity was not expressed by cough receptor nerve terminals in the tracheal wall.
Conclusion:
These data provide further insights into the neurochemistry of nodose cough receptors and suggest that despite their high degree of functional homogeneity, nodose cough receptors subtypes may eventually be distinguished based on neurochemical profile.</description>
        <link>http://www.coughjournal.com/content/4/1/9</link>
                <dc:creator>Stuart Mazzone</dc:creator>
                <dc:creator>Alice McGovern</dc:creator>
                <dc:source>Cough 2008, 4:9</dc:source>
        <dc:date>2008-10-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-4-9</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2008-10-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.coughjournal.com/content/4/1/8">
        <title>Simultaneous versus video counting of coughs in hypertonic cough challenges</title>
        <description>Background:
The coughs occurring during cough provocation tests are usually counted at the same time when the test is being conducted, i.e., simultaneously. It is unknown whether cough counting from video recording might increase the accuracy of the cough counting. During recent years, cough challenges with hypertonic aerosols have been introduced. They often provoke very frequent coughing which may complicate the simultaneous cough counting.ObjectiveTo assess whether cough counting from video recording is superior to simultaneous cough counting in two different hypertonic cough challenges.
Methods:
The analysis includes 82 hypertonic saline challenges performed on 66 subjects, providing 1984 observation minutes with both simultaneous and video cough counting. The cough sensitivity was expressed as the osmolality to provoke 15 cumulative coughs (CUM15). The analysis also includes 136 hypertonic histamine challenges performed on 114 subjects providing 5373 observation minutes with both simultaneous and video counting. The cough sensitivity was expressed as the cumulative number of coughs divided by the final histamine concentration administered (CCR). This challenge involved several additional measurements to cough counting.
Results:
For the saline challenge, the mean difference between the counting types was 0.0 coughs per minute with 95% limits of agreement of -1.2 to 1.2 coughs per minute. For the hypertonic histamine challenge the respective figures were 0.3 (-1.9 to 2.5) coughs per minute. At high coughing frequency the video counts tended to outnumber the simultaneous counts. The counting type had no effect on the hypertonic saline CUM15 and only a marginal effect on its repeatability. On the contrary, video counting resulted to significantly higher hypertonic histamine CCR values than simultaneous counting (p &lt; 0.001).
Conclusion:
The agreement between simultaneous and video counting of coughs is generally good. However, as the coughing frequency increases, simultaneous counting may miss coughs, especially if the nurse has to share his/her attention to several activities simultaneously. Video recording is advisable for the hypertonic histamine challenge but unnecessary for the hypertonic saline challenge. To ensure reliable simultaneous cough counting, cough provocation tests should be performed in a quiet environment, applying as little unnecessary equipment and measurements as possible.</description>
        <link>http://www.coughjournal.com/content/4/1/8</link>
                <dc:creator>Heikki Koskela</dc:creator>
                <dc:creator>Minna Purokivi</dc:creator>
                <dc:creator>Raija Tukiainen</dc:creator>
                <dc:source>Cough 2008, 4:8</dc:source>
        <dc:date>2008-09-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-9974-4-8</dc:identifier>
        <prism:publicationName>Cough</prism:publicationName>
        <prism:issn>1745-9974</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2008-09-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
